KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Jun 10, 2020 $35.06 $35.79 $33.93 $35.01 1 014 917
Jun 09, 2020 $35.22 $35.91 $34.90 $35.14 691 708
Jun 08, 2020 $34.53 $35.74 $34.00 $35.74 797 365
Jun 05, 2020 $32.93 $34.54 $31.85 $34.07 1 154 649
Jun 04, 2020 $31.64 $32.97 $31.50 $32.45 1 100 453
Jun 03, 2020 $33.10 $33.25 $31.96 $32.01 721 011
Jun 02, 2020 $33.43 $33.52 $31.61 $32.77 951 307
Jun 01, 2020 $32.10 $33.65 $31.91 $33.31 1 015 654
May 29, 2020 $33.29 $33.42 $31.56 $32.24 1 622 395
May 28, 2020 $33.97 $34.62 $32.65 $33.09 1 184 691
May 27, 2020 $33.71 $34.23 $31.57 $33.67 1 872 226
May 26, 2020 $36.90 $36.96 $33.55 $33.71 1 114 160
May 22, 2020 $35.65 $35.85 $34.80 $35.69 587 337
May 21, 2020 $36.57 $36.82 $34.77 $35.84 971 675
May 20, 2020 $36.87 $37.39 $36.01 $36.63 1 008 683
May 19, 2020 $38.30 $38.96 $36.44 $36.49 1 090 397
May 18, 2020 $36.96 $38.96 $36.62 $38.24 1 400 598
May 15, 2020 $35.82 $36.32 $34.41 $35.85 953 304
May 14, 2020 $33.36 $36.01 $32.66 $35.60 1 454 469
May 13, 2020 $36.41 $37.25 $33.51 $34.16 1 156 340
May 12, 2020 $36.42 $38.16 $35.03 $35.94 1 379 626
May 11, 2020 $33.87 $37.29 $33.33 $36.30 1 522 059
May 08, 2020 $36.48 $37.10 $33.30 $34.14 1 761 737
May 07, 2020 $34.95 $35.44 $33.77 $35.13 1 241 300
May 06, 2020 $35.71 $35.87 $34.06 $34.23 819 065
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT